Literature DB >> 27416970

Role of fibroblast-derived factors in the pathogenesis of melasma.

J W Byun1, I S Park2, G S Choi1, J Shin1.   

Abstract

BACKGROUND: The hyperactive melanocytes present in melasma skin are confined to the epidermis, but epidermal ablation to treat melasma pigmentation may lead to disease recurrence and aggravation. Melanocyte function is regulated by interactions between melanocytes and neighbouring cells such as keratinocytes and fibroblasts. Because melasma skin usually shows dermal changes after exposure to sunlight, we hypothesized that sun-damaged fibroblasts might play a crucial role in the pathogenesis of melasma. AIM: In this study, the melanogenic role of primary cultured fibroblasts from human melasma skin was investigated.
METHODS: We explored whether primary cultured fibroblasts from melasma tissue have a melanogenic function on cultured human epidermal melanocytes and artificial skin. The cytokine profile derived from fibroblasts and their effect on the pigmented epidermal equivalents were investigated.
RESULTS: Fibroblasts from the melasma lesion and perilesional skin increased melanogenesis in cultured human epidermal melanocytes and in artificial skin. Fibroblasts from the melasma lesion and perilesional skin secreted more nerve growth factor (NGF)-β than those in normal buttock skin, and also increased melanogenesis and the expression level of NGF-β in cultured human epidermal melanocytes and artificial skin.
CONCLUSIONS: These results suggest that fibroblasts may play a role in melanogenesis and the pathogenesis of melasma.
© 2016 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27416970     DOI: 10.1111/ced.12874

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  11 in total

1.  Sebocytes contribute to melasma onset.

Authors:  Enrica Flori; Arianna Mastrofrancesco; Sarah Mosca; Monica Ottaviani; Stefania Briganti; Giorgia Cardinali; Angela Filoni; Norma Cameli; Marco Zaccarini; Christos C Zouboulis; Mauro Picardo
Journal:  iScience       Date:  2022-02-04

Review 2.  Participation of keratinocyte- and fibroblast-derived factors in melanocyte homeostasis, the response to UV, and pigmentary disorders.

Authors:  Parth R Upadhyay; Tina Ho; Zalfa A Abdel-Malek
Journal:  Pigment Cell Melanoma Res       Date:  2021-05-24       Impact factor: 4.693

3.  Deoxyarbutin Possesses a Potent Skin-Lightening Capacity with No Discernible Cytotoxicity against Melanosomes.

Authors:  Fang Miao; Ying Shi; Zhi-Feng Fan; Shan Jiang; Shi-Zheng Xu; Tie-Chi Lei
Journal:  PLoS One       Date:  2016-10-24       Impact factor: 3.240

4.  Assessment of the effects of skin microneedling as adjuvant therapy for facial melasma: a pilot study.

Authors:  Emerson V A Lima; Mariana Modesto D A Lima; Mauricio Pedreira Paixão; Hélio Amante Miot
Journal:  BMC Dermatol       Date:  2017-11-28

Review 5.  p75 Neurotrophin Receptor in the Skin: Beyond Its Neurotrophic Function.

Authors:  Carlo Pincelli
Journal:  Front Med (Lausanne)       Date:  2017-03-07

6.  Ultraviolet-irradiated endothelial cells secrete stem cell factor and induce epidermal pigmentation.

Authors:  Misun Kim; Takako Shibata; Soohyun Kwon; Tae Jun Park; Hee Young Kang
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

7.  Ursodeoxycholic Acid May Inhibit Environmental Aging-Associated Hyperpigmentation.

Authors:  Ik Jun Moon; Hanju Yoo; Seung Hwan Paik; Hak Tae Kim; Su Yeon Kim; Youngsup Song; Sung Eun Chang
Journal:  Antioxidants (Basel)       Date:  2021-02-09

Review 8.  Implications of Oxidative Stress in the Pathogenesis and Treatment of Hyperpigmentation Disorders.

Authors:  Xiaoxue Xing; Yanjun Dan; Zhongyi Xu; Leihong Xiang
Journal:  Oxid Med Cell Longev       Date:  2022-01-18       Impact factor: 6.543

9.  A Clinical and Biochemical Evaluation of a Temperature-Controlled Continuous Non-Invasive Radiofrequency Device for the Treatment of Melasma.

Authors:  Soon-Hyo Kwon; Jung-Im Na; Chang-Hun Huh; Kyoung-Chan Park
Journal:  Ann Dermatol       Date:  2021-11-04       Impact factor: 1.444

Review 10.  Update on Melasma-Part I: Pathogenesis.

Authors:  Ana Cláudia C Espósito; Daniel P Cassiano; Carolina N da Silva; Paula B Lima; Joana A F Dias; Karime Hassun; Ediléia Bagatin; Luciane D B Miot; Hélio Amante Miot
Journal:  Dermatol Ther (Heidelb)       Date:  2022-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.